Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers
The agreement brings an end to the legal dispute between the two companies. Hims & Hers shares jumped in morning trading.
----
Live Nation Reaches Settlement With DOJ in Antitrust Case
The move spares the concerts-and-ticketing giant from the threat of its business being broken up.
----
Nasdaq Partners With Kraken in Plan for 24/7 Tokenized Stock Trading
Nasdaq sought approval in September to let investors trade tokenized versions of its listed stocks and other exchange-traded products.
----
Simon & Schuster Names Former Amazon Executive Greeley as CEO
The publisher is turning to an industry outsider as expanded entertainment options squeeze the book business.
----
Nvidia-Backed Startup Nscale Raises Funds at $14.6 Billion Valuation
Nvidia, Dell Technologies and Nokia were among the investors that backed the AI infrastructure startup's Series C funding round.
----
Activist Starboard Takes Big Stake in French-Fry Maker Lamb Weston
Starboard Value is pushing the company to speed up improvements and cost cutting to boost its underperforming stock.
----
Roche Breast-Cancer Treatment Misses Goal in Late-Stage Study
Shares fell, wiping out year-to-date gains in the company's stock after it said the combination of giredestrant with Pfizer's Ibrance didn't meet its primary objective.
----
GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million
Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat.
----
Trump Sons Back New Drone Company Targeting Pentagon Sales
Powerus says it plans to acquire Ukrainian drone technology to sell to the U.S. military.
----
AI Needs Management Consultants After All
OpenAI, Anthropic strike deals with consulting firms to spread artificial intelligence through the business world.
----
Volkswagen Dealers Revolt Over Plan to Sell a New Brand of SUV Directly to Consumers
The latest of several lawsuits seeks to stop the automaker from bypassing dealerships.
(END) Dow Jones Newswires
March 09, 2026 11:00 ET (15:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.